|
2024
|
Invention
|
Modified cardiotropic aav capsid polypeptides and vectors. The present disclosure provides varian... |
|
|
Invention
|
Methods of treating alt-dependent cancers. The present disclosure generally relates to methods of... |
|
|
Invention
|
Aav capsids and vectors for transduction of cells of the peripheral nervous system. The present i... |
|
2023
|
Invention
|
Gene editing systems and uses therefor. The present disclosure relates generally to gene editing ... |
|
|
Invention
|
Adeno-associated virus capsids. Provided herein are AAV capsid polypeptides comprising peptide mo... |
|
2022
|
Invention
|
Methods and nucleic acid molecules for aav vector selection.
Provided herein are methods for ide... |
|
|
Invention
|
Methods and nucleic acid molecules for aav vector selection. Provided herein are methods for iden... |
|
|
Invention
|
Modified aav capsid polypeptides and vectors.
The present disclosure relates generally to modifi... |
|
|
Invention
|
Modified aav capsids and vectors.
The present disclosure relates generally to modified adeno-ass... |
|
|
Invention
|
Modified aav capsids and vectors. e.g.e.g. plasmids) comprising the encoding nucleic acids molecu... |
|
|
Invention
|
Modified aav capsid polypeptides and vectors. The present disclosure relates generally to modifie... |
|
|
Invention
|
Modified aav capsids and vectors. The present disclosure relates generally to modified adeno-asso... |
|
2021
|
Invention
|
Adeno-associated virus capsids and vectors.
The present disclosure relates generally to adeno-as... |
|
|
Invention
|
Aav capsids and vectors.
The present disclosure relates generally to adeno-associated vims (AAV)... |
|
|
Invention
|
Aav capsids and vectors. The present disclosure relates generally to adeno-associated virus (AAV)... |
|
|
Invention
|
Adeno-associated virus capsids and vectors. The present disclosure relates generally to adeno-ass... |
|
|
Invention
|
New dynamin inhibitors and uses. The present invention generally relates to the use of halodiamin... |
|
|
Invention
|
Adeno-associated virus capsid polypeptides and vectors.
The present disclosure relates generally... |
|
|
Invention
|
Adeno-associated virus capsid polypeptides and vectors. The present disclosure relates generally ... |
|
2020
|
Invention
|
Methods and aav vectors for in vivo transduction.
The present disclosure relates generally to me... |
|
|
Invention
|
In vivo transduction. in vivoin vivoin vivo, and methods for screening AAV vectors. The disclosur... |
|
|
Invention
|
Methods of treating cancer with an inhibitor of znf827.
The present disclosure relates to inhibi... |
|
|
Invention
|
Methods of treating cancer with an inhibitor of znf827. The present disclosure relates to inhibit... |
|
|
Invention
|
Treatment of alt cancers.
The present disclosure generally relates to cancer and the treatment o... |
|
|
Invention
|
Treatment of alt cancers. The present disclosure generally relates to cancer and the treatment of... |
|
2019
|
Invention
|
Nucleic acid molecules and methods for aav vector selection.
The present disclosure relates gene... |
|
|
Invention
|
Nucleic acid molecules and methods for aav vector selection. The present disclosure relates gener... |
|
|
Invention
|
Stable gene transfer to proliferating cells. Provided herein are methods for facilitating or indu... |
|
|
Invention
|
Aav polynucleotides, polypeptides and virions.
The present disclosure relates generally to polyp... |
|
|
Invention
|
Aav polynucleotides, polypeptides and virions. The present disclosure relates generally to polype... |
|
|
Invention
|
Methods for codon optimization. The present disclosure relates generally to methods for modifying... |
|
2018
|
Invention
|
Methods of assessing telomeres.
This invention relates generally to methods for assessing telome... |
|
|
Invention
|
Methods of assessing telomeres. This invention relates generally to methods for assessing telomer... |
|
|
Invention
|
Polynucleotides and vectors for the expression of transgenes. Polynucleotides and vectors can be ... |
|
|
Invention
|
Polynucleotides and vectors for the expression of transgenes. The present invention is directed t... |
|
2017
|
Invention
|
Adeno-associated virus polynucleotides, polypeptides and virions. Polypeptides are encoded by an ... |
|
|
Invention
|
Adeno-associated virus polynucleotides, polypeptides and virions. The present disclosure relates ... |
|
|
P/S
|
Software and computer programs in respect of medical, proteomic and genetic analysis and testing;... |
|
|
P/S
|
Software and computer programs including, but not limited
to, software and computer programs in ... |
|
|
P/S
|
Software and computer programs for use in medical, proteomic, molecular and genetic analysis and ... |
|
2016
|
Invention
|
Promoters for expression of heterologous genes. The present disclosure relates generally to promo... |
|
2012
|
Invention
|
Inhibition of clathrin. Inhibitors are provided for inhibiting the activity of clathrin. In parti... |
|
|
P/S
|
Chemicals for use in the pharmaceutical industry; chemical reagents for research; laboratory chem... |
|
|
P/S
|
Chemicals for use in the pharmaceutical industry; chemical
reagents for research; laboratory che... |
|
|
P/S
|
Chemicals for use in medical and veterinary analysis, namely, medical diagnostic reagents for the... |
|
|
P/S
|
Chemicals for use in medical and veterinary analysis;
chemicals for use in medical and veterinar... |
|
2010
|
Invention
|
Methods and assays for the detection of alternative lengthening of telomeres (alt) activity in ce... |
|
|
Invention
|
Use of dynamin ring stabilizers. There is provided a method for promoting dynamin ring formation ... |
|
2009
|
Invention
|
Compositions and methods for inhibition of adipogenesis and the treatment of obesity. Methods for... |
